stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Net income
Intuitive Surgical, Inc.'s net income for fiscal 2025 was $2.9B, up 23.1% from $2.3B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.0B. Over the past ten years it has ranged from $588.8M (fiscal 2015) to $2.9B (fiscal 2025) — the current reading is the highest in ten years. Net income has risen for 3 consecutive fiscal years. Intuitive Surgical, Inc. ranks 1st of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $2.9B | 23.06% |
| FY2024 | $2.3B | 28.62% |
| FY2023 | $1.8B | 35.18% |
| FY2022 | $1.3B | (22.20%) |
| FY2021 | $1.7B | 61.99% |
| FY2020 | $1.1B | (22.80%) |
| FY2019 | $1.4B | 22.83% |
| FY2018 | $1.1B | 67.69% |
| FY2017 | $670.9M | (9.13%) |
| FY2016 | $738.3M | 25.39% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $524.4M | (36.30%) |
| Jun 2026 | $823.2M | (0.34%) |
| Mar 2026 | $826.0M | 3.31% |
| Dec 2025 | $799.5M | 12.73% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| ISRG Intuitive Surgical, Inc. | $3.0B |
| MDLN Medline Inc. compare | $1.9B |
| RMD ResMed Inc. compare | $1.6B |
| BDX Becton, Dickinson and Company compare | $942.0M |
| ALC Alcon compare | $643.0M |
| WST West Pharmaceutical Services, Inc. compare | $638.9M |
| COO The Cooper Companies, Inc. compare | $570.3M |
| SOLV Solventum Corporation compare | $156.0M |
| BAX Baxter International Inc. compare | −$723.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ISRG
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement